Canaccord Genuity on AtriCure Inc. (ATRC): Bottom Line - Buy on Weakness
Tweet Send to a Friend
Canaccord Genuity maintains a 'Buy' on AtriCure Inc. (NASDAQ: ATRC) price target lowered to $12.00.
Analyst, Jason R ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Jason R ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
